Here you can browse the Appendices to the Minutes of Evidence which were ordered by the House of Commons to be printed 6 June 2000.
APPENDIX 1 Supplementary memorandum by the Department of Health (TB 1A)
APPENDIX 2 Memorandum by the National Asthma Campaign (TB 2)
APPENDIX 3 Memorandum by the Director General The Cancer Research Campaign (TB 5)
APPENDIX 4 Memorandum by Mr Nigel Gray (TB 6)
APPENDIX 5 Memorandum by the Roy Castle Lung Cancer Foundation (TB 7)
APPENDIX 6 Memorandum by the Consumers' Association (TB 10)
APPENDIX 7 Memorandum by the British Dental Health Foundation (TB 15)
APPENDIX 8 Memorandum by the British Dental Association (TB 16)
APPENDIX 9 Memorandum by the Stroke Association (TB 17)
APPENDIX 10 Joint memorandum by the NHS Confederation and the Local Authority Co-ordinating Body for Food and Trading Standards (TB 22)
APPENDIX 11 Memorandum by Imperial Cancer Research Fund (TB 24)
APPENDIX 12 Supplementary memorandum by the BMA (TB 25A)
APPENDIX 13 Letter from the Director European Heart Network to the Clerk of the Committee (TB 27)
Annex Extract of a Citizens' Petition before the Food and Drug Administration Washington DC
APPENDIX 14 Memorandum by the Medical Research Council (TB 29)
APPENDIX 15 Memorandum by Judith Watt (TB 32)
APPENDIX 16 Memorandum by Professor Sir Richard Peto (TB 44)
APPENDIX 17 Letter from Mr Stephen Woodward, Health Education Authority to the Chairman of the Committee (TB 20A)
APPENDIX 18 Letter from Professor Jack E Hennifield to the Clerk of the Committee (TB 30)
APPENDIX 19 Memorandum by Pharmacia and Upjohn (TB 33)
APPENDIX 20 Letter from Mr Martin Day, Leigh Day and Co Solicitors to the Clerk of the Committee (TB 35A)
Smoking Related Diseases Possible Claim for Health Care Costs
APPENDIX 21 Letter from Dr John Slade to the Clerk of the Committee (TB 26)
APPENDIX 22 Memorandum by Tyne and Wear Health Action Zone (TB 53)
APPENDIX 23 Letter from the Health Education Authority to the Clerk of the Committee (TB 20B)
APPENDIX 24 Note from Dr Caroline Shenton, Record Office, House of Lords (TB 54)
APPENDIX 25 Supplementary memorandum by British American Tobacco (TB 28F)
APPENDIX 26 Memorandum by Centre For Tobacco Control Research, University of Strathclyde (TB 56)
APPENDIX 27 Supplementary memorandum by British American Tobacco (TB 28D)
APPENDIX 28 Letter from the Head of Corporate Affairs Gallaher Group Plc to the Clerk of the Committee (TB 8E)
APPENDIX 29 Letter from the Clerk of the Committee to the Head of Corporate Affairs Gallaher Group Plc
Letter from the Head of Corporate Affairs Gallaher Group Plc to the Clerk of the Committee (TB 8F)
APPENDIX 30 Supplementary memorandum by the Department of Health
APPENDIX 31 Further supplementary memorandum by the Department of Health (TB 1D)
APPENDIX 32 Supplementary evidence by British American Tobacco (TB 28E)
APPENDIX 33 Supplementary evidence by Gallaher Group Plc (TB 8D)
APPENDIX 34 Supplementary evidence by Imperial Tobacco Group Plc (TB 13D)
APPENDIX 35 Supplementary evidence by Philip Morris
Prior Disclosure to Department of Health With Brand Variant Identified
APPENDIX 36 Supplementary evidence by R J Reynolds Tobacco (UK) Limited (TB 31B)
APPENDIX 37 Letter from the Head of Corporate Affairs Gallaher Group Plc to the Clerk of the Committee (TB 8G)
APPENDIX 38 Note by Mr Frank Cranmer, Principal Clerk Select Committees to the Clerk of the Committees, Professor Roger Perry (TB 62)
APPENDIX 39 Extracts from the Register of Members' Interests as at 31 January 1999 (TB 63)
APPENDIX 40 Letter from the Minister of Health People's Republic of China to the Chairman of the Committee (TB 63)
APPENDIX 41 Letter from the Corporate Affairs Director Imperial Tobacco Group Plc, to the Clerk of the Committee (TB 13F)
APPENDIX 42 Letter from the Vice President Corporate Affairs, Philip Morris, European Union Region to the Clerk of the Committee (TB 19D)
Extract from The Independent, Thursday, 24 March 1988
Extract from The Times, Monday, 13 June 1988
Annex 1
Annex 2
APPENDIX 43 Supplementary memorandum by Judith Watt (TB 32A)
APPENDIX 44 Memorandum by the Faculty of Public Health Medicine (TB 11)